A Study of Rozanolixizumab in Pediatric Study Participants With Moderate to Severe Generalized Myasthenia Gravis
Clinical trial NCT06149559 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06149559
- Sponsor
- UCB Biopharma SRL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-14
- Primary completion
- 2026-08-10
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.